As a science-driven company, our greatest contribution to society is developing innovative medicines and diagnostics that help people live healthier lives. Roche is committed to the Science Based ...

Presented at the Clinical Trials in Alzheimer’s Disease congress, being held in Madrid, Spain, Roche’s diagnostics unit showed that a negative result from one test—its Elecsys amyloid plasma ...

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out ...

Led by Roche Center team members and in collaboration with leading experts and researchers at Boston College and around the world, the Roche Center offers innovative professional learning and ...

A survey by Roche Diagnostics of 2,836 women aged 25 to 50 from eight Asia-Pacific countries discovered that 44 per cent of respondents delayed or avoided medical treatment because of familial ...

Agrawal is the chief scientific officer of DH Diagnostics LLC, a subsidiary of Danaher Corporation. It’s been 13 years since the term “precision medicine” was coined, and its promise ...

Healthcare solutions provider Qure.ai has entered into a collaboration with Roche Diagnostics Asia Pacific’s Startup Creasphere (APAC) initiative to work on AI-driven medical imaging technologies.

MANNHEIM, Germany, Oct 9 (Reuters) - Roche's (ROG.S), opens new tab experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ($12 billion ...

BOSTON -- I can't recall the first time that I met Luis Tiant. But I can tell you that I was in awe when it happened. "El Tiante" was second only to Carl Yastrzemski when it came to Boston Red Sox ...

Brian Roche co-anchors News 8 at 5 p.m. each weekday. He is also the 8 On Your Side Consumer/Investigative reporter for News 8. Brian is an Emmy Award winning anchor and reporter. He has been ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...